These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31064817)

  • 41. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.
    Faccini J; Ruidavets JB; Cordelier P; Martins F; Maoret JJ; Bongard V; Ferrières J; Roncalli J; Elbaz M; Vindis C
    Sci Rep; 2017 Feb; 7():42916. PubMed ID: 28205634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis.
    Wang F; Long G; Zhao C; Li H; Chaugai S; Wang Y; Chen C; Wang DW
    J Transl Med; 2013 Sep; 11():222. PubMed ID: 24053180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
    Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease].
    Nie X; Su L; Zhou Y; Zhao Y; Shi D; Liu Y; Zhou Z; Zhou Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jul; 42(7):561-5. PubMed ID: 25327597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating microRNA-33b levels are associated with the presence and severity of coronary heart disease.
    Chen C; Liu Q; Li Y; Yu JW; Wang SD; Xu JL; Liu L
    Scand J Clin Lab Invest; 2024 Apr; 84(2):133-137. PubMed ID: 38597780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between microRNA-206 plasma levels with the severity of coronary artery conflicts in patients with coronary artery disease.
    Zehtabian SH; Alibakhshi R; Seyedena SY; Rai AR
    Bratisl Lek Listy; 2019; 120(8):581-585. PubMed ID: 31379181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
    Ding H; Hu CX; Xu JK
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease.
    Ren J; Zhang J; Xu N; Han G; Geng Q; Song J; Li S; Zhao J; Chen H
    PLoS One; 2013; 8(12):e80738. PubMed ID: 24339880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL.
    Mishra S; Rizvi A; Pradhan A; Perrone MA; Ali W
    Prostaglandins Other Lipid Mediat; 2021 Apr; 153():106536. PubMed ID: 33556577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis.
    Saavedra N; Rojas G; Herrera J; Rebolledo C; Ruedlinger J; Bustos L; Bobadilla B; Pérez L; Saavedra K; Zambrano T; Lanas F; Salazar LA
    Biomed Res Int; 2020; 2020():2509039. PubMed ID: 33015157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating miR-106b-5p serves as a diagnostic biomarker for asymptomatic carotid artery stenosis and predicts the occurrence of cerebral ischemic events.
    Zhang T; Chen Z; Yang X; Fu R; Wang J; Xu H
    Vasc Med; 2020 Oct; 25(5):436-442. PubMed ID: 32558619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic value of circulating microRNAs for middle-aged (40-60-year-old) coronary artery disease patients.
    Sayed AS; Xia K; Li F; Deng X; Salma U; Li T; Deng H; Yang D; Haoyang Z; Yang T; Peng J
    Clinics (Sao Paulo); 2015 Apr; 70(4):257-63. PubMed ID: 26017792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China.
    Liu M; Jiang S; Ma Y; Ma J; Hassan W; Shang J
    Lipids Health Dis; 2018 Jul; 17(1):154. PubMed ID: 30021655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
    Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
    Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
    Chen W; Li S
    Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of insulin-like growth factor-1 with severity of coronary artery disease.
    Yousefzadeh G; Masoomi M; Emadzadeh A; Shahesmaeili A; Sheikhvatan M
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):416-20. PubMed ID: 23160066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
    Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
    J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients.
    Muendlein A; Geiger K; Leiherer A; Saely CH; Fraunberger P; Drexel H
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F315-F321. PubMed ID: 31813253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.